Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-11 08:19 am Purchase | 13G | PULMONX CORP LUNG | FMR LLC | 4,654,399 12.077% | 1,344,898 (+40.64%) | View |
| 2024-02-29 4:31 pm Purchase | 13G | PULMONX CORP LUNG | Point72 Asset Management L.P. | 1,936,083 5% | 389,994 (+25.22%) | View |
| 2024-02-14 06:17 am Sale | 13G | PULMONX CORP LUNG | Point72 Asset Management L.P. | 1,546,089 4% | -425,721 (-21.59%) | View |
| 2024-02-13 5:12 pm Sale | 13G | PULMONX CORP LUNG | VANGUARD GROUP INC | 2,066,442 5.39% | -353,178 (-14.60%) | View |
| 2024-02-13 3:42 pm Sale | 13G | PULMONX CORP LUNG | Champlain Investment Partners LLC | 0 0% | -2,701,250 (Position Closed) | View |
| 2024-02-12 5:30 pm Sale | 13G | PULMONX CORP LUNG | Flynn James E | 6,009 0.02% | -2,459,254 (-99.76%) | View |
| 2024-02-12 4:01 pm Purchase | 13G | PULMONX CORP LUNG | PRIMECAP MANAGEMENT CO | 5,646,451 14.74% | 143,730 (+2.61%) | View |
| 2024-02-09 10:21 am Purchase | 13G | PULMONX CORP LUNG | MORGAN STANLEY MS | 2,061,758 5.4% | 110,168 (+5.65%) | View |
| 2024-02-09 09:49 am Purchase | 13G | PULMONX CORP LUNG | FMR LLC | 3,309,501 8.639% | 3,309,501 (New Position) | View |
| 2024-01-25 4:59 pm Purchase | 13G | PULMONX CORP LUNG | BlackRock Inc. BLK | 3,117,063 8.1% | 423,423 (+15.72%) | View |
| 2023-02-14 3:46 pm Sale | 13G | PULMONX CORP LUNG | PURA VIDA INVESTMENTS LLC | 1,216,258 3.25% | -661,864 (-35.24%) | View |
| 2023-02-13 5:28 pm Purchase | 13G | PULMONX CORP LUNG | Flynn James E | 2,465,263 6.59% | 2,465,263 (New Position) | View |
| 2023-02-13 5:03 pm Sale | 13G | PULMONX CORP LUNG | Flynn James E | 0 0% | -2,366,867 (Position Closed) | View |
| 2023-02-13 3:33 pm Sale | 13G | PULMONX CORP LUNG | Capital World Investors | 0 0% | -2,754,500 (Position Closed) | View |
| 2023-02-13 3:20 pm Purchase | 13G | PULMONX CORP LUNG | Champlain Investment Partners LLC | 2,701,250 7.22% | 614,105 (+29.42%) | View |
| 2023-02-10 2:30 pm Purchase | 13G | PULMONX CORP LUNG | MORGAN STANLEY MS | 1,951,590 5.2% | 1,951,590 (New Position) | View |
| 2023-02-09 4:01 pm Purchase | 13G | PULMONX CORP LUNG | PRIMECAP MANAGEMENT CO | 5,502,721 14.71% | 558,830 (+11.30%) | View |
| 2023-02-09 11:30 am Sale | 13G | PULMONX CORP LUNG | VANGUARD GROUP INC | 2,419,620 6.47% | -104,868 (-4.15%) | View |
| 2023-01-31 1:58 pm Sale | 13G | PULMONX CORP LUNG | BlackRock Inc. BLK | 2,693,640 7.2% | -24,691 (-0.91%) | View |
| 2023-01-04 5:04 pm Purchase | 13G | PULMONX CORP LUNG | Point72 Asset Management L.P. | 1,971,810 5.3% | 1,971,810 (New Position) | View |